Market Overview

Benzinga's Top Downgrades

Related ATU
Actuant Misses Q2 Expectations, Issues Downbeat Outlook
Earnings Scheduled For March 18, 2015
Related XYL
Oppenheimer Went To The EPG Conference; Here's What Happened
Xylem Joins Bipartisan Policy Center's New Business Leader Council

Analysts at Citigroup downgraded Actuant (NYSE: ATU) from “buy” to “neutral.” Actuant's shares closed at $25.81 yesterday. Actuant's trailing-twelve-month ROE is 14.43%.

Analysts at Goldman downgraded Xylem (NYSE: XYL) from “neutral” to “sell.” Xylem's shares closed at $24.29 yesterday. Xylem's PEG ratio is 2.33.

Analysts at Bernstein downgraded Weatherford International Ltd (NYSE: WFT) from “outperform” to “market perform.” Weatherford's shares closed at $12.24 yesterday. Weatherford's trailing-twelve-month profit margin is 2.53%.

JMP Securities downgraded Anthera Pharmaceuticals (NASDAQ: ANTH) from “outperform” to “market perform.” Anthera Pharmaceuticals' shares closed at $2.75 yesterday. Anthera Pharmaceuticals' trailing-twelve-month ROA is -92.62%.

Latest Ratings for ATU

Mar 2015Stifel NicolausDowngradesBuyHold
Mar 2015BMO CapitalMaintainsMarket Perform
Jan 2015JefferiesMaintainsHold

View More Analyst Ratings for ATU
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (ATU + ANTH)

Around the Web, We're Loving...